Thursday, May 31, 2018
7:30am—6:00pm
Bauer Hall 230 (2nd Floor)
Olin Business School
Washington University at St. Louis
St. Louis, MO 63130
(map)
Agenda
7:30am–8:00am | Registration Check-In and Continental Breakfast |
8:00am–8:45am | Welcome, Introductions, and Background Anjan Thakor, Washington University in St. Louis Mark Wrighton, Washington University in St. Louis Andrew W. Lo, MIT |
8:45am–10:00am | Opportunities and Challenges in Oncology Therapeutic Development Facilitator: David Perlmutter, Washington University School of Medicine Initial Comments: Tim Eberlein, Siteman Cancer Center; Michael Goldberg, Dana-Farber Cancer Institute; Parag Mallick, Stanford; Marty Tenenbaum, Cancer Commons |
10:00am–10:15am | Break |
10:15am–11:30pm | Generating Clinical Evidence: Trial Design and Analytics Facilitator: Anna Barker, Arizona State University Initial Comments: Laura Esserman, UCSF; Leah Isakov, Seqirus; Sean Khozin, FDA Oncology Center of Excellence; Martin Murphy, Project DataSphere; Kailash Swarna, MIT Laboratory for Financial Engineering |
11:30am–1:00pm | Lunch Location: McGinnis Classroom (Bauer Hall 210) Keynote Address: Greg Simon, Biden Cancer Initiative Introduction by: Mark Taylor, Olin Business School, Washington University in St. Louis |
1:00pm–1:15pm | Break |
1:15pm–2:30pm | Stakeholder Perspectives Facilitator: Len Lichtenfeld, American Cancer Society Initial Comments: Todd Haim, National Cancer Institute; Richard Hamermesh, Harvard Business School; Marc Hurlbert, Breast Cancer Research Foundation; Anna Makki, Torreya Partners |
2:30pm–2:45pm | Break |
2:45pm–4:00pm | Potential Business Models and Financing Structures Facilitator: Michael Kinch, Washington University Initial Comments: Lucas de Breed, Inkef Capital; Amit Kumar, ITUS Corporation; Thomas Melzer, RiverVest Ventures; Laura Thrall |
4:00pm–4:30pm | Wrap-Up, Next Steps, and Closing Remarks Holden Thorp, Washington University in St. Louis Andrew Lo |
4:30pm–6:00pm | Cocktail Reception and Conversation Location: Knight/Bauer Hall Frick Forum |